Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Similar presentations


Presentation on theme: "Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,"— Presentation transcript:

1 Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease 
Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port, MD, Paul C. Lee, MD, Subroto Paul, MD, Nasser K. Altorki, MD  The Annals of Thoracic Surgery  Volume 92, Issue 2, Pages (August 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival for the cohort, stratified by clinical T stage: blue line indicates cT2; green line indicates cT3. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival of patients receiving induction therapy followed by surgery (green line) versus patients undergoing surgery alone (blue line [p = 0.465]). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Overall survival of pN+ patients (green line) versus pN0 patients (blue line): 5-year estimates, 35.0% versus 72.1% (p = 0.003). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,"

Similar presentations


Ads by Google